Tykhe Financial Statements From 2010 to 2025

HALB Stock  USD 0  0.0003  15.79%   
Tykhe Corp's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tykhe Corp's valuation are provided below:
Tykhe Corp does not presently have any fundamental trend indicators for analysis.
Check Tykhe Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tykhe Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Tykhe financial statements analysis is a perfect complement when working with Tykhe Corp Valuation or Volatility modules.
  
This module can also supplement various Tykhe Corp Technical models . Check out the analysis of Tykhe Corp Correlation against competitors.

Tykhe Corp Company Current Valuation Analysis

Tykhe Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Tykhe Corp Current Valuation

    
  1.56 M  
Most of Tykhe Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tykhe Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Tykhe Corp has a Current Valuation of 1.56 M. This is 99.99% lower than that of the Healthcare sector and 99.97% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.99% higher than that of the company.

Tykhe Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tykhe Corp's current stock value. Our valuation model uses many indicators to compare Tykhe Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tykhe Corp competition to find correlations between indicators driving Tykhe Corp's intrinsic value. More Info.
Tykhe Corp is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tykhe Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tykhe Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Tykhe Corp Financial Statements

Tykhe Corp stakeholders use historical fundamental indicators, such as Tykhe Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tykhe Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tykhe Corp's assets and liabilities are reflected in the revenues and expenses on Tykhe Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tykhe Corp. Please read more on our technical analysis and fundamental analysis pages.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania. HALBERD CORP is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tykhe Pink Sheet

Tykhe Corp financial ratios help investors to determine whether Tykhe Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tykhe with respect to the benefits of owning Tykhe Corp security.